Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trial

A R Naylor1, A Bolia, R J Abbott

  • 1Department of Vascular Surgery, Leicester Royal Infirmary, United Kingdom.

Insights

Carotid angioplasty (CA) showed a significantly higher stroke risk compared to carotid endarterectomy (CEA) in patients with severe internal carotid artery disease. The trial was halted due to safety concerns and ethical issues.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Carotid angioplasty (CA) is proposed as a safer, cost-effective alternative to carotid endarterectomy (CEA) for symptomatic severe internal carotid artery (ICA) disease.
  • This study aimed to compare the safety and efficacy of CA versus CEA.

Purpose of the Study:

  • To evaluate the outcomes of carotid angioplasty (CA) compared to carotid endarterectomy (CEA) in patients with symptomatic severe internal carotid artery stenosis.
  • To assess the incidence of death or stroke within 30 days post-procedure.

Main Methods:

  • A prospective, randomized trial comparing CEA with CA in patients with severe ICA stenosis (>70%) and symptoms.
  • 17 patients received allocated treatment before trial suspension: 10 underwent CEA, 7 underwent CA.
  • Outcomes included death or disabling/nondisabling stroke within 30 days.

Main Results:

  • All 10 carotid endarterectomy (CEA) procedures were completed without complications.
  • Five of seven patients (71%) undergoing carotid angioplasty (CA) experienced a stroke, with three being disabling (P=.0034).

Conclusions:

  • The trial was suspended due to a high stroke rate in the CA group and informed consent issues.
  • Ethical dilemmas encountered highlight the need for rigorous protocol adherence in future trials.
  • Careful documentation of inclusion/exclusion criteria is crucial for any future studies on carotid angioplasty.
Abstract